Global neonatal intensive care equipment industry expected to reach $1.36 billion by 2030

DUBLIN, June 15, 2022 /PRNewswire/ — The “Neonatal Intensive Care Equipment Market Size, Share, and Trend Analysis Report by Type (Thermoregulation, Phototherapy, Monitoring, Respiratory), by Region (North America, EuropeACPA, Latin AmericaMEA), and sector forecasts, 2022-2030 » report has been added to from ResearchAndMarkets.com offer.

The global neonatal intensive care equipment market size is expected to reach $1.36 billion in 2030, expanding to a CAGR 8.70%. Growing number of premature births, increasing incidence of newborn jaundice, and new product launches are some of the factors responsible for the growth of the market. The neonatal intensive care unit (NICU) offers treatment for premature babies and those with breathing problems, anemia, heart defects and other conditions that require intensive care.

The majority of NICU admissions are for premature babies. To support their treatment, various organizations offer financial assistance to health care providers. For example, in October 2018, the Australian government has announced a provision of AUD 600,000 to the Miracle Babies Foundation to support the families of premature babies. The number of cases of jaundice and respiratory problems in newborns is increasing and precautionary measures are being taken by government authorities. For example, the government is increasing the number of NICU facilities to address newborn health issues.

However, neonatal deaths are a major concern in developing and developed economies, with a significant difference in mortality rates. According to the OECD, in 2018, the countries of the Southeast and South Asia neonatal deaths reported compared to East Asian countries. A mortality rate of over 20 per 1,000 live births has been recorded in India & Burmawith more than 40 per 1,000 in Pakistan.

On the other hand, countries like Australia, Japan, SingaporeKorea and China reported approximately 2 deaths per 1,000 live births. Although the death rate in the United States is lower than in developing economies, it remains high, with 47% of the 2.4 million (112,800) newborn deaths in 2019 occurring during the neonatal period. To counter this problem, there is a growing demand for neonatal monitoring and care equipment.

Additionally, given the high number of newborn deaths in developing economies, startups are focusing on product innovations. Coeo Labs, an Indian MedTech start-up, has designed a neonatal CPAP system that can help reduce deaths from respiratory distress syndrome (RDS) during neonatal transport. In addition, financial assistance is provided to local manufacturers in India as part of the government’s make-in India program.

The COVID-19 pandemic has, in some countries, resulted in pregnant women receiving less care due to lockdown restrictions, leading to complications leading to stillbirth. According to a study published in August 2020 in The Lancet Global Health, stillbirths in Nepal went from 14 per 1,000 births before confinement (end March 2020) to 21 per 1,000 births by the end of May 2020, an increase of almost 50%. Such situations have amplified the production of neonatal intensive care equipment to ensure premature babies are protected from the virus.

Highlights of the Neonatal Intensive Care Equipment Market Report

  • On the basis of type, the respiratory equipment segment led the market in terms of revenue share in 2021 due to the high prevalence of respiratory disorders in newborn babies.
  • North America dominated the neonatal intensive care equipment market in 2021 owing to the strategic presence of major players and high healthcare expenditures and measures adopted by organizations to improve neonatal healthcare.
  • The Asia Pacific is likely to record remarkable growth linked to a high birth rate in the region.
  • Manufacturers of neonatal intensive care equipment undertake research and development to provide innovative products to meet the growing demand for NICUs globally.
  • In December 2019, Masimo has received FDA clearance for its RD SET pulse oximetry sensors for neonates (weighing more than 3 kg). Initially available for newborns under 3 kg, approval makes it available for all newborns in the United States

Main topics covered:

Chapter 1. Methodology and scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends and Scope
3.1 Market Segmentation
3.2 Mapping of penetration and growth prospects
3.2.1 Penetration analysis
3.2.2 Market Driver Analysis
3.2.3 Market Restraint Analysis
3.3 Neonatal Intensive Care Equipment Market: Business Environment Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.2 Pestel analysis
3.4 Neonatal Intensive Care Equipment Market: Qualitative Analysis of the Impact of Covid-19

Chapter 4. Neonatal Intensive Care Equipment Market: Type Analysis
4.1 Neonatal Intensive Care Equipment Type Market Share Analysis, 2021 & 2030
4.2 Neonatal Intensive Care Equipment Type Market: Segment Scorecard:
4.3 Market Size & Forecast and Trend Analysis, 2021 & 2030 for Type Segment
4.3.1 Thermoregulation equipment
4.3.1.1 Thermoregulation Equipment Market, 2016-2030 (Million USD)
4.3.2 Phototherapy equipment
4.3.2.1 Phototherapy Equipment Market, 2016- 2030 (Million USD)
4.3.3 Monitoring equipment
4.3.3.1 Surveillance Equipment Market, 2016-2030 (Million USD)
4.3.3 Respiratory system
4.3.3.1 Respiratory Equipment Market, 2016-2030 (USD Million)
4.3.3 Others
4.3.3.1 Others Market, 2016-2030 (Million USD)

Chapter 5. Neonatal Intensive Care Equipment Market: Regional Analysis

Chapter 6. Competitive Analysis
6.1 Recent Developments and Impact Analysis, by Major Market Players
6.2 Strategic Framework/Competition Categorization (Key Innovators, Market Leaders, Emerging Players
6.3 Company Market Position Analysis
6.4 Company Profiles
6.4.1 Cardinal Health
6.4.1.1 Presentation of the company
6.4.1.2 Product Benchmarking
6.4.1.3 Strategic initiatives
6.4.2 Dragerwerk Ag & Co. Kgaa
6.4.2.1 Presentation of the company
6.4.2.2 Financial performance
6.4.2.3 Product Benchmarking
6.4.3 Vyaire Medical, Inc.
6.4.3.1 Presentation of the company
6.4.3.2 Product Benchmarking
6.4.3.3 Strategic initiatives
6.4.4 Ge Health
6.4.4.1 Presentation of the company
6.4.4.2 Financial performance
6.4.4.3 Product Benchmarking
6.4.4.4 Strategic initiatives
6.4.5 Medtronic
6.4.5.1 Presentation of the company
6.4.5.2 Financial performance
6.4.5.3 Product Benchmarking
6.4.5.4 Strategic initiatives
6.4.6 DB
6.4.6.1 Presentation of the company
6.4.6.2 Financial performance
6.4.6.3 Product Benchmarking
6.4.6.4 Strategic initiatives
6.4.7 Utah Medical Products, Inc.
6.4.7.1 Presentation of the company
6.4.7.2 Financial performance
6.4.7.3 Product Benchmarking
6.4.7.4 Strategic initiatives
6.4.8 AMBU A/S
6.4.8.1 Presentation of the company
6.4.8.2 Financial performance
6.4.8.3 Product Benchmarking
6.4.8.4 Strategic initiatives
6.4.9 Natus Medical Incorporated
6.4.9.1 Presentation of the company
6.4.9.2 Financial performance
6.4.9.3 Product Benchmarking
6.4.9.4 Strategic initiatives
6.4.10 Inspiration Healthcare Group Plc
6.4.10.1 Presentation of the company
6.4.10.2 Financial performance
6.4.10.3 Product Benchmarking
6.4.10.4 Strategic initiatives
6.4.11 Koninklijke Philips NV
6.4.11.1 Presentation of the company
6.4.11.2 Financial performance
6.4.11.3 Product Benchmarking
6.4.11.4 Strategic initiatives

For more information on this report, visit https://www.researchandmarkets.com/r/cxog1k

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716

SOURCE Research and Markets

Comments are closed.